Articles in Business

Zacks.com

Varian Products Expand to Algeria - Analyst Blog

As a part of its strategy to expand its reach in the global economy, Varian Medical Systems ( VAR ) announced the sale of its products to the Algerian government. The Varian Clinac iX... Read >>

Zacks.com

New High for Constellation Brands - Analyst Blog

Yesterday, the shares of Constellation Brands Inc. ( STZ ) reached a new 52-week high of $39.65, beating its previous 52-week high of $38.99 attained on Jan 17. Continued synergies from the... Read >>

Zacks.com

Magna Remains Neutral - Analyst Blog

On Jan 24, we maintained our Neutral recommendation on Magna International Inc. ( MGA ) despite its significant acquisitions and expansion strategy and improved third quarter 2012 earnings,... Read >>

Zacks.com

Nasdaq Modifies Business Structure - Analyst Blog

Yesterday, Nasdaq OMX Group Inc. ( NDAQ ) announced the merger of its Global Data Products and Global Index businesses to form a new reporting segment - Global Information Services.... Read >>

Zacks.com

Altria Expected to Beat Estimates - Analyst Blog

We expect tobacco giant Altria Group Inc . ( MO ) to beat expectations when it reports fourth quarter and full year fiscal 2012 results on Jan 31 before the market opens. Why a Likely... Read >>

Zacks.com

Helmerich & Payne: Likely to Beat - Analyst Blog

We expect oil and gas drilling contractor Helmerich & Payne Inc. ( HP ) to beat expectations when it reports first-quarter fiscal 2013 results before the opening bell tomorrow,... Read >>

Zacks.com

FirstEnergy Submits Rate Info to PSC - Analyst Blog

FirstEnergy Corporation 's ( FE ) business wings, Mon Power and Potomac Edison, submitted additional rate information to West Virginia's Public Service Commission ("PSC")... Read >>

Zacks.com

US Nod for ISIS/Sanofi's Kynamro - Analyst Blog

The US Food and Drug Administration (FDA) recently approved Kynamro (mipomersen sodium) injection developed by Genzyme, a Sanofi company ( SNY ) and Isis Pharmaceuticals Inc. ( ISIS ).... Read >>

Zacks.com

Santarus Files Suit against Mylan - Analyst Blog

Santarus, Inc. ( SNTS ) recently filed a patent infringement lawsuit against Mylan, Inc. ( MYL ) which is looking to launch a generic version of Santarus' Fenoglide (fenofibrate - 40 mg... Read >>

Zacks.com

Earnings Preview: Merck - Analyst Blog

Merck & Co. Inc. ( MRK ) is scheduled to report its fourth quarter 2012 results on Feb 1, 2013 before the opening bell. Last quarter, the company posted a 2.15% positive... Read >>